Jerome Lynch

Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY.

Production Services Network's primary business is to provide long-term brown-field support for customers who operate existing oil and gas facilities whether that be platforms, pipelines or terminals. The services it provides include engineering, hook-up and commissioning, project management, operations, maintenance and construction. PSN is a dynamic and flexible global business with a diverse customer base of major independent integrated oil companies, national oil companies, utilities companies and refineries. Its unique network structure enables the company to execute projects in some of the world's most difficult operating environments. Tried and tested systems let the company start up quickly. Its sustainable business methods mean that it aims to develop local workforces, with its values, to deliver its clients projects. It has a reputation for safety and integrity wherever it operates; the safety of its people and those it works with them is its top priority. Safety is its number one core value; its seven core values shape its business and guide its decision making.